These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 4537665

  • 21. Studies on the subcellular localization of corticotrophin releasing factor (CRF) and vasopressin in the median eminence of the rat.
    Mulder AH, Geuze JJ, de Wied D.
    Endocrinology; 1970 Jul; 87(1):61-79. PubMed ID: 4315594
    [No Abstract] [Full Text] [Related]

  • 22. [Ultrastructural changes of pancreatic B cells of the islands of Langerhans induced by the electrical stimulation of the hypothalamus and autonomic nerve endings].
    Sakagami M.
    Kaibogaku Zasshi; 1972 Apr 01; 47(2):154-71. PubMed ID: 4558690
    [No Abstract] [Full Text] [Related]

  • 23. Corticotropin releasing factor increases in brown adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus and medullary raphe pallidus.
    Cerri M, Morrison SF.
    Neuroscience; 2006 Jun 30; 140(2):711-21. PubMed ID: 16580142
    [Abstract] [Full Text] [Related]

  • 24. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats.
    Swiergiel AH, Li Y, Wei ZY, Dunn AJ.
    Neurochem Int; 2008 May 30; 52(6):1220-5. PubMed ID: 18280616
    [Abstract] [Full Text] [Related]

  • 25. Subcellular distribution of corticotropin-releasing factor in the medio-basal hypothalamus of the rat.
    Briaud B, Enjalbert A, Mialhe C, Kordon C.
    Neuroendocrinology; 1979 May 30; 28(6):371-6. PubMed ID: 313532
    [Abstract] [Full Text] [Related]

  • 26. [Lipid peroxidation during synaptosome depolarization].
    Nikushkin EV, Kucherianu VG.
    Biull Eksp Biol Med; 1993 Mar 30; 115(3):244-5. PubMed ID: 8054605
    [Abstract] [Full Text] [Related]

  • 27. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
    Bagosi Z, Jászberényi M, Szabó G, Telegdy G.
    Brain Res Bull; 2008 Jan 31; 75(1):15-7. PubMed ID: 18158090
    [Abstract] [Full Text] [Related]

  • 28. Corticotrophin-releasing factor type 2 receptor-mediated suppression of gonadotrophin-releasing hormone mRNA expression in GT1-7 cells.
    Kinsey-Jones JS, Li XF, Bowe JE, Lightman SL, O'Byrne KT.
    Stress; 2006 Dec 31; 9(4):215-22. PubMed ID: 17175507
    [Abstract] [Full Text] [Related]

  • 29. Localized increases in corticotropin-releasing factor receptors in pulp after dental injury.
    Rutz JC, Hatton JF, Hildebolt C, Wells JE, Rowland KC.
    J Endod; 2007 Nov 31; 33(11):1319-24. PubMed ID: 17963955
    [Abstract] [Full Text] [Related]

  • 30. Early development of cerebellar afferent systems that contain corticotropin-releasing factor.
    Cummings SL, Young WS, King JS.
    J Comp Neurol; 1994 Dec 22; 350(4):534-49. PubMed ID: 7890829
    [Abstract] [Full Text] [Related]

  • 31. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin.
    Rivier C, Lee S.
    Brain Res; 1996 Jul 08; 726(1-2):1-10. PubMed ID: 8836539
    [Abstract] [Full Text] [Related]

  • 32. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1996 May 08; 277(2):877-84. PubMed ID: 8627570
    [Abstract] [Full Text] [Related]

  • 33. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation.
    Tebbe JJ, Mronga S, Tebbe CG, Ortmann E, Arnold R, Schäfer MK.
    J Neuroendocrinol; 2005 Sep 08; 17(9):570-6. PubMed ID: 16101895
    [Abstract] [Full Text] [Related]

  • 34. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP, Clarke IJ, Funder JW, Engler D.
    J Clin Invest; 1994 Apr 08; 93(4):1439-50. PubMed ID: 8163648
    [Abstract] [Full Text] [Related]

  • 35. An improved methodology for the large-scale extraction and purification of porcine hypothalamic corticotrophin releasing factor [proceedings].
    Bristow AF, Jenkins G, Montague D, Schulster D.
    J Endocrinol; 1979 May 08; 81(2):126P-127P. PubMed ID: 313428
    [No Abstract] [Full Text] [Related]

  • 36. Corticotrophin releasing factor.
    Buckingham JC.
    Pharmacol Rev; 1979 Dec 08; 31(4):253-75. PubMed ID: 399808
    [No Abstract] [Full Text] [Related]

  • 37. Release of noradrenaline from the hypothalamus in vivo.
    Philippu A, Heyd G, Burger A.
    Eur J Pharmacol; 1970 Jan 08; 9(1):52-8. PubMed ID: 5434293
    [No Abstract] [Full Text] [Related]

  • 38. [Pocket nerve stimulators: are they suitable for monitoring curarization?].
    Meistelman C, Thirion B, Damia E.
    Ann Fr Anesth Reanim; 1989 Jan 08; 8 Suppl():R134. PubMed ID: 2604094
    [No Abstract] [Full Text] [Related]

  • 39. Has corticotropin-releasing factor finally been found?
    Fink G.
    Nature; 1981 Dec 10; 294(5841):511-2. PubMed ID: 6975894
    [No Abstract] [Full Text] [Related]

  • 40. Further evidence for peripheral activation of olivocochlear bundle endings.
    Nieder P, Nieder I.
    J Acoust Soc Am; 1970 Feb 10; 47(2):661-3. PubMed ID: 5439668
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.